Howard S. Schwartz advises public and private companies on strategic and day-to-day corporate, finance and commercial issues, including mergers and acquisitions; collaborations; debt and equity financings; critical commercial decisions; securities law disclosures; intellectual property acquisition, development and commercialization; product life cycle management; compliance programs; and bet-the-company transactions.

Howard is a former co-chair of our Life Sciences practice group and has a special concentration on pharma, medical device, and biotech companies. He is recognized as a leading practitioner in his field by his peers, including in recent editions of The Best Lawyers in America for the practice area of Biotechnology.